Seed Funds for Digital Twin Company BluePill

Seattle company BluePill has raised $6m in seed funding, for a platform using digital twins to predict consumer reaction to new products, ideas and campaigns.

BluePill uses millions of data points including behavioral signals, surveys and interviews to build AI personas which 'think and decide like real customers,' and continuously benchmarks the results against live human panels to validate their performance.

Founder & CEO Ankit Dhawan (pictured) worked previously at Amazon, where he says he 'saw what customers did but not why they did it- 'giving him the idea for the company. He states 'Our AI consumers uncover those motivations instantly, and when combined with human validation, deliver accuracy traditional research can't match.'

The round was led by Ubiquity Ventures, with participation from Pioneer Square Labs and Flying Fish Ventures.

BluePill says it will expand to offer AI audiences for specific sectors including CPG, healthcare, sports, media and entertainment, each continuously validated against human benchmarks.

The firm is online at www.blue-pill.ai .